Medicare Enrolled

Dr. Libu Varughese, MD

Endocrinology · Sugar Land, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1441 HIGHWAY 6 STE 100, Sugar Land, TX 77478
8329687003
Registered in NPPES since 2013
NPI: 1053750331 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Varughese from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Varughese? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Varughese

Dr. Libu Varughese is an endocrinology specialist in Sugar Land, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Varughese performed 752 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Varughese received a total of $9,650 from 43 pharmaceutical and/or device companies across 422 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Varughese is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years of NPI registration ▲ 752 Medicare services $9,650 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
752
Medicare services
Bottom 47% in TX for endocrinology
Not available
Unique patients (not deduplicated)
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
346 $90 $217
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
102 $91 $250
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
79 $124 $299
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
75 $26 $100
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
67 $56 $146
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
37 $133 $300
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
33 $61 $250
New patient office visit, complex (60-74 min) 13 $148 $346
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,650
Total received (2018-2024)
Avg $1,379/year across 7 years
Top 33% in TX for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
422
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,416
2023
$2,163
2022
$1,476
2021
$1,365
2020
$657
2019
$258
2018
$315

Payments by company (2024)

Lilly USA, LLC
$412
SANOFI-AVENTIS U.S. LLC
$307
Insulet Corporation
$279
Amgen Inc.
$268
Novo Nordisk Inc
$223
Corcept Therapeutics
$221
Alexion Pharmaceuticals, Inc.
$184
Boehringer Ingelheim Pharmaceuticals, Inc.
$166
ABBVIE INC.
$140
Embecta Corp.
$131
RECORDATI_RARE_DISEASES_INC.
$116
Radius Health, Inc.
$110
BETA BIONICS, INC.
$104
Xeris Pharmaceuticals, Inc.
$103
Dexcom, Inc.
$92
Mannkind Corporation
$83
Tandem Diabetes Care, Inc.
$79
Bayer Healthcare Pharmaceuticals Inc.
$78
Abbott Laboratories
$74
AstraZeneca Pharmaceuticals LP
$50
Kyowa Kirin, Inc.
$48
Medtronic, Inc.
$37
IBSA Pharma Inc.
$33
TheracosBio, LLC
$23
PFIZER INC.
$20
Ultragenyx Pharmaceutical Inc.
$19
Acella Pharmaceuticals, LLC
$16
Top 3 companies account for 29.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,005
Lilly USA, LLC
$823
Corcept Therapeutics
$774
Amgen Inc.
$693
SANOFI-AVENTIS U.S. LLC
$591
AstraZeneca Pharmaceuticals LP
$487
MannKind Corporation
$478
Tandem Diabetes Care, Inc.
$446
Mannkind Corporation
$387
Boehringer Ingelheim Pharmaceuticals, Inc.
$368
Abbott Laboratories
$329
Xeris Pharmaceuticals, Inc.
$316
Medtronic, Inc.
$285
Insulet Corporation
$279
Alexion Pharmaceuticals, Inc.
$252
Dexcom, Inc.
$210
Horizon Therapeutics plc
$192
ABBVIE INC.
$183
RECORDATI_RARE_DISEASES_INC.
$178
Radius Health, Inc.
$159
Embecta Corp.
$157
PFIZER INC.
$130
Bayer Healthcare Pharmaceuticals Inc.
$116
Valeritas, Inc.
$116
BETA BIONICS, INC.
$104
IBSA Pharma Inc.
$85
Nevro Corp.
$56
Kyowa Kirin, Inc.
$48
AbbVie Inc.
$43
Ultragenyx Pharmaceutical Inc.
$40
CeQur Corporation
$38
Janssen Pharmaceuticals, Inc
$37
Medtronic MiniMed, Inc.
$36
Amneal Pharmaceuticals LLC
$34
Ascendis Pharma Inc
$27
EUSA Pharma (US) LLC
$26
TheracosBio, LLC
$23
DEXCOM, INC.
$21
Ipsen Biopharmaceuticals, Inc
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$18
Acella Pharmaceuticals, LLC
$16
GRT US Holding, Inc.
$15
Novartis Pharmaceuticals Corporation
$13
Top 3 companies account for 27.0% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · BD Nano 2nd Gen Pen Needle · Brenzavvy · CINCH · CRYSVITA · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ETERNA · EVENITY · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · INTELLIS ADAPTIVESTIM · INVOKANA · ISTURISA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · MINIMED 780G · MOUNJARO · MULTAQ · Minimed 670G System · NP Thyroid 60 · Omnipod · Ozempic · PROCLAIM · Prolia · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SKYTROFA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STRENSIQ · SYNTHROID · Senza · Sylvant · TEPEZZA · TOUJEO · TRADJENTA · TZIELD · Tirosint · Tymlos · UBRELVY · UNITHROID · V-GO · Wegovy · XARELTO · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an endocrinology specialist in Sugar Land?
Compare endocrinologists in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists in nearby ZIP areas
121
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
ST LUKE'S SUGAR LAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Varughese is a clinical cardiology specialist, with moderate Medicare volume.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Varughese experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Varughese performed 346 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Varughese receive payments from pharmaceutical companies?
Yes. Dr. Varughese received a total of $9,650 from 43 companies across 422 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Varughese's costs compare to other endocrinologists in Sugar Land?
Dr. Varughese's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Varughese) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →